Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands

被引:10
作者
Vos, Cornelis F. [1 ,2 ]
Aarnoutse, Rob E. [3 ]
Op de Coul, Marijke J. M. [4 ]
Spijker, Jan [4 ,5 ]
Groothedde-Kuyvenhoven, Mascha M. [6 ,7 ]
Mihaescu, Raluca [8 ]
Wessels-Basten, Sonja J. W. [8 ]
Rovers, Jordy J. E. [9 ]
ter Hark, Sophie E. [1 ,2 ]
Schene, Aart H. [1 ,2 ]
Hulscher, Marlies E. J. L. [10 ]
Janzing, Joost G. E. [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Reinier Postlaan 10, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pharm Radboud Inst Hlth Sci, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Nijmegen, Netherlands
[5] Pro Persona, Nijmegen, Netherlands
[6] Deventer Hosp, Deventer, Netherlands
[7] Dimence Grp, Deventer, Netherlands
[8] Catharina Hosp, Eindhoven, Netherlands
[9] Vincent van Gogh Inst Psychiat, Venray, Netherlands
[10] Radboud Univ Nijmegen, Sci Ctr Qual Hlthcare, Med Ctr, Nijmegen, Netherlands
关键词
Antidepressant agents; Clinical practice guidelines; Qualitative approach; Major depressive disorder; Tricyclic antidepressants; GUIDELINES;
D O I
10.1186/s12888-021-03490-x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Traditionally tricyclic antidepressants (TCAs) have an important place in treatment of major depressive disorder (MDD). Today, often other antidepressant medications are considered as first step in the pharmacological treatment of MDD, mainly because they are associated with less adverse effects, whereby the position of TCAs appears unclear. In this study we aimed to examine the current practice of TCAs in treatment of unipolar MDD. Methods A mixed methods approach was applied. First, a selection of leading international and national guidelines was reviewed. Second, actual TCA prescription was examined by analyzing health records of 75 MDD patients treated with the TCAs nortriptyline, clomipramine or imipramine in different centers in the Netherlands. Third, promotors and barriers influencing the choice for TCAs and dosing strategies were explored using semi-structured interviews with 24 Dutch psychiatrists. Results Clinical practice guidelines were sometimes indirective and inconsistent with each other. Health records revealed that most patients (71%) attained therapeutic plasma concentrations within two months of TCA use. Patients who achieved therapeutic plasma concentrations reached them on average after 19.6 days (SD 10.9). Both health records and interviews indicated that therapeutic nortriptyline concentrations were attained faster compared to other TCAs. Various factors were identified influencing the choice for TCAs and dosing by psychiatrists. Conclusions Guideline recommendations and clinical practice regarding TCA prescription for MDD vary. To increase consistency in clinical practice we recommend development of an up-to-date guideline integrating selection and dosing of TCAs, including the roles of therapeutic drug monitoring and pharmacogenetics. Such a guideline is currently lacking and would contribute to optimal TCA treatment, whereby efficacy and tolerability may be increased.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Electrophysiological predictors of early response to antidepressants in major depressive disorder
    Tang, Hao
    Xia, Yi
    Hua, Lingling
    Dai, Zhongpeng
    Wang, Xiaoqin
    Yao, ZhiJian
    Lu, Qing
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 365 : 509 - 517
  • [12] Effectiveness of antidepressants in the treatment of major depressive disorder in Latin America
    Duenas, Hector J.
    Dwight, Trisha
    McBride, Margaret E.
    Brnabic, Alan J. M.
    Semper, Luis A.
    Holmgren, Dagmar
    Miranda-Scippa, Angela M. A.
    Rincon, Hernan G.
    Aguilera, Hector
    Vargas, Adrian
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (02) : 129 - 139
  • [13] The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice
    Hou, Zhenghua
    Jiang, Wenhao
    Yin, Yingying
    Zhang, Zhijun
    Yuan, Yonggui
    NEUROSCIENCE BULLETIN, 2016, 32 (04) : 389 - 397
  • [14] Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom
    Hugh Freeman
    Steve Arikian
    Alan Lenox-Smith
    PharmacoEconomics, 2000, 18 : 143 - 148
  • [15] The Current Situation on Major Depressive Disorder in China:Research on Mechanisms and Clinical Practice
    Zhenghua Hou
    Wenhao Jiang
    Yingying Yin
    Zhijun Zhang
    Yonggui Yuan
    NeuroscienceBulletin, 2016, 32 (04) : 389 - 397
  • [16] The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice
    Zhenghua Hou
    Wenhao Jiang
    Yingying Yin
    Zhijun Zhang
    Yonggui Yuan
    Neuroscience Bulletin, 2016, 32 : 389 - 397
  • [17] Combination of Antidepressants in the Treatment of Major Depressive Disorder A Systematic Review and Meta-Analysis
    Rocha, Fabio Lopes
    Fuzikawa, Cintia
    Riera, Rachel
    Hara, Claudia
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (02) : 278 - 281
  • [18] Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
    Caroline Kamp Jørgensen
    Sophie Juul
    Faiza Siddiqui
    Marija Barbateskovic
    Klaus Munkholm
    Michael Pascal Hengartner
    Irving Kirsch
    Christian Gluud
    Janus Christian Jakobsen
    Systematic Reviews, 10
  • [19] Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder
    Cha, Danielle S.
    Luo, Xinyi
    Ahmed, Juhie
    Becirovic, Larissa
    Cha, Rebekah H.
    McIntyre, Roger S.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (09) : 777 - 783
  • [20] Nutritional considerations in major depressive disorder: current evidence and functional testing for clinical practice
    Khiroya, Kathryn
    Sekyere, Eric
    McEwen, Bradley
    Bayes, Jessica
    NUTRITION RESEARCH REVIEWS, 2023,